Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VENA Stock Summary
In the News
VENA Financial details
Company Rating
Neutral
Market Cap
459.18M
Income
-11.74M
Revenue
125.2M
Book val./share
13.77
Cash/share
4.38
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
30 Mar 2021
P/E
-4.13
Forward P/E
-
PEG
0.67
P/S
0.38
P/B
0.5
P/C
-
P/FCF
-94.9
Quick Ratio
2.69
Current Ratio
6.98
Debt / Equity
0.02
LT Debt / Equity
0
-
-
EPS (TTM)
-0.67
EPS next Y
-
EPS next Q
-
EPS this Y
377.01%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
13.49%
EPS Q/Q
220.69%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-11%
ROE
-18%
ROC
-0.14%
Gross Margin
23%
Oper. Margin
-9%
Profit Margin
-8%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.2742-16.17
52W High
-
52W Low
-
RSI
-
Rel Volume
0.08
Avg Volume
48.76K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
VENA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 1.07 | 20.97 | 21.86 | 17.95 | |
Net income per share | 0 | 0.32 | 2.16 | -1.74 | -8.3 | |
Operating cash flow per share | 0 | 0.34 | 3.9 | 0.49 | -1.41 | |
Free cash flow per share | 0 | 0.33 | 3.89 | 0.45 | -1.41 | |
Cash per share | 0.07 | 0.85 | 10.79 | 10.72 | 10.39 | |
Book value per share | 0 | 1.11 | 14.75 | 16.75 | 9.95 | |
Tangible book value per share | 0 | 0.5 | 8.16 | 12.74 | 10.06 | |
Share holders equity per share | 0 | 1.11 | 14.75 | 16.75 | 9.95 | |
Interest debt per share | 0.07 | 0.05 | 0.15 | 0.06 | 0.45 | |
Market cap | 588.06M | 27.82B | 2.54B | 49.83M | 41.6M | |
Enterprise value | 588.08M | 27.78B | 2.5B | 7.26M | -1.24M | |
P/E ratio | -118.2K | 1.99K | 296.9 | -7.2 | -1.1 | |
Price to sales ratio | 0 | 590.51 | 30.64 | 0.57 | 0.51 | |
POCF ratio | -118.2K | 1.89K | 164.56 | 25.48 | -6.49 | |
PFCF ratio | -118.2K | 1.9K | 164.95 | 27.77 | -6.49 | |
P/B Ratio | 41.63K | 572.41 | 43.55 | 0.75 | 0.92 | |
PTB ratio | 41.63K | 572.41 | 43.55 | 0.75 | 0.92 | |
EV to sales | 0 | 589.77 | 30.13 | 0.08 | -0.02 | |
Enterprise value over EBITDA | -118.21K | 1.82K | 195.78 | 5 | 0.07 | |
EV to operating cash flow | -118.21K | 1.89K | 161.82 | 3.71 | 0.19 | |
EV to free cash flow | -118.21K | 1.89K | 162.2 | 4.05 | 0.19 | |
Earnings yield | 0 | 0 | 0 | -0.14 | -0.91 | |
Free cash flow yield | 0 | 0 | 0.01 | 0.04 | -0.15 | |
Debt to equity | 31.86 | 0.05 | 0.01 | 0 | 0.04 | |
Debt to assets | 0.9 | 0.03 | 0 | 0 | 0.03 | |
Net debt to EBITDA | -4.36 | -2.28 | -3.32 | -29.32 | 2.43 | |
Current ratio | 0.89 | 1.96 | 2.46 | 11.49 | 4.79 | |
Interest coverage | 0 | 88.13 | 39.68 | -1.04 | -215.73 | |
Income quality | 1 | 1.05 | 1.8 | -0.28 | 0.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.05 | 0.06 | 0.06 | 0 | |
Research and developement to revenue | 0 | 0.05 | 0.2 | 0.16 | 0.28 | |
Intangibles to total assets | 0 | 0.36 | 0.32 | 0.23 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | -0.08 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | -0.08 | -0.02 | -0.11 | 0 | |
Stock based compensation to revenue | 0 | 0.01 | 0.04 | 0 | -0.01 | |
Graham number | 0.01 | 2.82 | 26.79 | 25.58 | 43.1 | |
ROIC | -0.01 | 0.27 | 0.19 | 0 | -0.39 | |
Return on tangible assets | -0.01 | 0.3 | 0.15 | -0.12 | -0.65 | |
Graham Net | -0.01 | 0.41 | 6.33 | 11.09 | 8.28 | |
Working capital | -55.48K | 22.8M | 32.04M | 50.41M | 45.6M | |
Tangible asset value | 14.13K | 22.13M | 32.33M | 50.79M | 45.92M | |
Net current asset value | -55.48K | 21.65M | 31.04M | 50.14M | 45.6M | |
Invested capital | 31.86 | 0.05 | 0.01 | 0 | 0.04 | |
Average receivables | 0 | 4M | 7.26M | 7.56M | 5.93M | |
Average payables | 0 | 816.31K | 1.84M | 2.05M | 2.5M | |
Average inventory | 0 | 72.7K | 484.62K | 477.18K | 65.26K | |
Days sales outstanding | 0 | 61.97 | 28.63 | 36.07 | 14.48 | |
Days payables outstanding | 0 | 21.32 | 15.14 | 10.93 | 18.82 | |
Days of inventory on hand | 0 | 1.9 | 6.07 | 0.7 | 0 | |
Receivables turnover | 0 | 5.89 | 12.75 | 10.12 | 25.21 | |
Payables turnover | 0 | 17.12 | 24.12 | 33.39 | 19.4 | |
Inventory turnover | 0 | 192.25 | 60.1 | 522.36 | 0 | |
ROE | -0.35 | 0.29 | 0.15 | -0.1 | -0.83 | |
Capex per share | 0 | 0 | -0.01 | -0.04 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.14 | 0 | 2.19 | 4.07 | 4.61 | |
Net income per share | 0.3 | 0.72 | -0.17 | -0.29 | -0.93 | |
Operating cash flow per share | -0.03 | -0.14 | 0.06 | -0.63 | -0.87 | |
Free cash flow per share | -0.03 | -0.14 | 0.05 | -0.64 | -0.86 | |
Cash per share | 10.04 | 0.03 | 1.07 | 4.79 | 4.38 | |
Book value per share | 12.61 | 74.08 | 1.67 | 15.2 | 13.77 | |
Tangible book value per share | 7.28 | 74.08 | 1.27 | 11.52 | 10.12 | |
Share holders equity per share | 12.61 | 74.08 | 1.67 | 15.2 | 13.77 | |
Interest debt per share | 0.07 | 3.49 | -0.01 | 0.05 | 0.29 | |
Market cap | 3.15B | 62.62M | 498.25M | 90.78M | 101.31M | |
Enterprise value | 3.1B | 64.71M | 455.69M | 69.99M | 83.36M | |
P/E ratio | 576.94 | 36.13 | -18.27 | -17.94 | -6.19 | |
Price to sales ratio | 111.54 | 0 | 5.72 | 5.09 | 5.01 | |
POCF ratio | -25.02K | -757.52 | 221.79 | -32.87 | -26.48 | |
PFCF ratio | -25.56K | -757.52 | 238.9 | -32.24 | -26.86 | |
P/B Ratio | 54.3 | 1.4 | 7.46 | 1.36 | 1.68 | |
PTB ratio | 54.3 | 1.4 | 7.46 | 1.36 | 1.68 | |
EV to sales | 109.96 | 0 | 5.23 | 3.93 | 4.12 | |
Enterprise value over EBITDA | 1.99K | -646.74 | -81.91 | -56.78 | -61.35 | |
EV to operating cash flow | -24.66K | -782.87 | 202.84 | -25.35 | -21.79 | |
EV to free cash flow | -25.2K | -782.87 | 218.49 | -24.86 | -22.11 | |
Earnings yield | 0 | 0.01 | -0.01 | -0.01 | -0.04 | |
Free cash flow yield | 0 | 0 | 0 | -0.03 | -0.04 | |
Debt to equity | 0 | 0.05 | 0 | 0 | 0.02 | |
Debt to assets | 0 | 0.04 | 0 | 0 | 0.02 | |
Net debt to EBITDA | -28.7 | -20.94 | 7.65 | 16.86 | 13.21 | |
Current ratio | 2.43 | 0.02 | 11.49 | 6.98 | 4.81 | |
Interest coverage | 41.79 | 0 | 13.61 | -94.11 | -87.17 | |
Income quality | -0.09 | -0.19 | -0.37 | 2.18 | 0.8 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.04 | 0 | 0.05 | 0.06 | 0 | |
Research and developement to revenue | 0.1 | 0 | -0.16 | 0.29 | 0.4 | |
Intangibles to total assets | 0.3 | 0 | 0.23 | 0.22 | 0.22 | |
Capex to operating cash flow | -0.02 | 0 | -0.07 | 0.02 | -0.01 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0.01 | 0 | -0.11 | -0.51 | 22.04 | |
Stock based compensation to revenue | 0 | 0 | -0.01 | 0 | 0 | |
Graham number | 9.17 | 34.55 | 2.54 | 9.93 | 17.01 | |
ROIC | 0.02 | 0 | -0.09 | -0.02 | -0.03 | |
Return on tangible assets | 0.02 | 0.01 | -0.12 | -0.02 | -0.07 | |
Graham Net | 5.86 | -5.51 | 1.11 | 4.56 | 3.99 | |
Working capital | 32.77M | -2.16M | 50.41M | 50.3M | 44.26M | |
Tangible asset value | 33.47M | 44.82M | 50.79M | 50.53M | 44.37M | |
Net current asset value | 31.97M | -3.32M | 50.14M | 50M | 44.01M | |
Invested capital | 0 | 0.05 | 0 | 0 | 0.02 | |
Average receivables | 2.89M | 2.89M | 4.31M | 18.07M | 28.89M | |
Average payables | 806.28K | 806.28K | 1.02M | 2.22M | 3.65M | |
Average inventory | 158.33K | 158.33K | 65.26K | -12.87M | -25.45M | |
Days sales outstanding | 18.4 | 0 | 8.89 | 138.94 | 134.5 | |
Days payables outstanding | 6.23 | 0 | 2.7 | 16.73 | 32.59 | |
Days of inventory on hand | 1.22 | 0 | 0.17 | -180.89 | -166.04 | |
Receivables turnover | 4.89 | 0 | 10.12 | 0.65 | 0.67 | |
Payables turnover | 14.44 | 0 | 33.39 | 5.38 | 2.76 | |
Inventory turnover | 73.54 | 0 | 522.36 | -0.5 | -0.54 | |
ROE | 0.02 | 0.01 | -0.1 | -0.02 | -0.07 | |
Capex per share | 0 | 0 | 0 | -0.01 | 0.01 |
VENA Frequently Asked Questions
What is Venus Acquisition Corporation stock symbol ?
Venus Acquisition Corporation is a US stock , located in New york of Ny and trading under the symbol VENA
What is Venus Acquisition Corporation stock quote today ?
Venus Acquisition Corporation stock price is $- today.
Is Venus Acquisition Corporation stock public?
Yes, Venus Acquisition Corporation is a publicly traded company.